Intrarosa for Dsypareunia in Menopause Gets FDA Approval
FDA approved intrarosa to treat menopause-associated dyspareunia.
FDA approved intrarosa to treat menopause-associated dyspareunia.
Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.
Musculoskeletal pain that affected physical function and quality of life was common in severely obese adolescents who underwent bariatric surgery.
Projections indicate that the incidence and costs of fractures related to osteoporosis will double by 2035 in China, according to new data.
Patients with diabetic peripheral neuropathy may be at an increased risk for falling while climbing or descending stairs.